Make faster, better drug development decisions
With increasing competition and complexity, the chance of successfully getting your oncology drug to market will fall even lower than the current 4%. It is therefore more crucial than ever to stay informed and adapt to market trends and opportunities, to ensure you can maximise your chance of success.
Beacon Oncology is the one stop shop for drug developers who value high quality data and comprehensiveness to make the best-informed decisions.
How can you have confidence in your oncology R&D decisions if you are missing 40% of the drugs and trials in the landscape? Have conviction in decisions, maximise your commercial strategy and stay ahead of your competition with the most comprehensive, accurate drug development insight available.
+25k DRUGS
The most comprehensive oncology-focused drug database available, featuring over 25,000 drug records and continually expanding, with the capability to integrate the oncology dataset with our additional modules.
+30k TRIALS
A searchable, standardized database of drug and trial data, serving as a single source of truth that covers the entire landscape.
50+ FILTERS
What we cover
ALL ONCOLOGY TRIALS
Every Oncology clinical trial since 2011 , including chemotherapies
+25k DRUGS & THERAPIES
Every Drug or Therapy deployed in those trials both active and inactive
INCLUDING ACTIVE & INACTIVE
Every active or inactive preclinical oncology Drug or Therapy reaching back to 2011
How Beacon works
UPDATES WITHIN 48HRS
Data updated within 24-48hrs of any public disclosure
AAA ACCURACY
All data curated to current exacting standard of accuracy
50+ FILTERS
All Tier 1 Beacon filters – providing over 50 variables to search by
What our customers say
Beacon is a great database that people should pay attention to. It's much better than many generic databases that try to capture all data about everything.
Director
Top Biotech Company
Any questions? Contact us
To learn more about how we can tailor Beacon Oncology to help you, get in touch with our sales team
About Beacon
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies and the most accurate and comprehensive life sciences data provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
Other Beacon Solutions
Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more
Covering all genetically and non-genetically engineered allogeneic and autologous cell-based therapies across all disease indications
Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more
Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.
Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets
Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.
Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.
From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.
Covering all therapeutics aimed at treating immune-mediated diseases – Beacon Immune Tolerance provides drug developers with detailed views of the expanding immune tolerance landscape.
Covering all pharmaceutical grade microbiome-based therapeutics across all disease indications – Beacon Microbiome provides drug developers with detailed views of the expanding microbiome landscape.
Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.
Beacon TPD provides the solution you need to master the targeted protein degradation field.
